We are developing a next generation test to assess patients with chest pain: a high-sensitivity troponin test that will seek to enable faster diagnosis of heart attack or rule-out/discharge of low-risk patients. Safe discharge reduces unnecessary hospital admissions, reduces crowding in the emergency department and cuts costs to the healthcare system significantly.

Emergency physicians need sensitive, precise lab results to guide treatment or safe discharge for patients with chest pain. Professional guidelines are driving the shift to high-sensitivity troponin assays, which can diagnose or rule-out heart attack 4 to 6 hours earlier than contemporary troponin tests.